Westlake Precision Birth Cohort

Status Active, not recruiting

Clinical Trial Summary

The Westlake Precision Birth Cohort (WeBirth) is a prospective cohort study among women with hyperglycemia during pregnancy and their offspring living in Hangzhou, China. The primary aim of this cohort is to characterize the continuous blood glucose response to dietary intake and physical activity among pregnant women with gestational diabetes mellitus (GDM) over 2 weeks, and to facilitate the development of personalized nutritional/lifestyle recommendation among these patients. Another aim of WeBirth is to investigate the association of dietary intake and physical activity together with continuous glucose change during pregnancy on the adverse birth outcomes including preterm birth, macrosomia and large-for-gestational-age birth. The secondary aim is to investigate the prospective associations of diet, physical activity and continuous glucose change over 2 weeks among the participants with long-term metabolic health of these women and their offspring.

Clinical Trial Description

In China, an alarming increase in the prevalence of GDM has been observed in the past decade. GDM is of concern because it is associated with several maternal and fetal medical disorders. Lifestyle changes such as diet and physical activity modifications are key for the prevention and treatment of GDM. However, the associations between dietary intake and physical activity and health outcomes for GDM women and their children remain unclear due to subjective measurements of diet and physical activity. Recently, the development of objective measurements such as food image identification and wearable activity trackers give an opportunity to gain more precise insight into these associations. In addition, for the same food and physical activity exposures, GDM women may have different blood glucose responses, but the nature of variation is currently poorly characterized. Therefore, the present WeBirth design incorporates three unique components, 1) objective measurement of physical activity during pregnancy using accelerometer; 2) measurement of dietary intake using both the Food Frequency Questionnaire and dietary records; 3) measurement of blood glucose levels over 2 weeks using continuous glucose monitors, with three standardized test meals during the 2 weeks. We will then follow up these women participants during and after this pregnancy, and also follow up their offspring. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04060056
Study type	Interventional
Source	Westlake University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	August 30, 2019
Completion date	August 31, 2029

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02577536` - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting	`NCT06437782` - Exploration of Health Literacy in Diabetes in Reunion Island and France
Completed	`NCT01940003` - Effects of an Aquatic Physical Exercise Program on Glycaemic Control and Perinatal Outcomes of Gestational Diabetes: Study Protocol for a Randomized Controlled Trial	N/A
Completed	`NCT02960295` - The Virtual Visit for Women With Gestational Diabetes	N/A
Completed	`NCT01919476` - Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women	N/A
Completed	`NCT05512871` - A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM)	N/A
Enrolling by invitation	`NCT03307486` - Gestational Diabetes: a Cohort Study	N/A
Active, not recruiting	`NCT04417452` - Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy
Completed	`NCT02968628` - Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
Active, not recruiting	`NCT04222348` - MeDiGes Study: Metformine Use in Gestational Diabetes	Phase 3
Completed	`NCT03007186` - Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
Completed	`NCT00069576` - Gestational Diabetes Mellitus Trial (GDM)	N/A
Completed	`NCT04866823` - Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes	N/A
Recruiting	`NCT04198857` - Development and Testing of a Mobile Health Application for Management of Gestational Diabetes	N/A
Recruiting	`NCT05115188` - DIAgnosing GDM usiNg Oral Sugar InStead	Phase 2
Recruiting	`NCT03607799` - A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes	N/A
Recruiting	`NCT02893072` - Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study	N/A
Enrolling by invitation	`NCT05368220` - Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
Completed	`NCT02770079` - Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.
Completed	`NCT00681460` - Metformin in Gestational Diabetes Mellitus	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Westlake Precision Birth Cohort — WeBirth

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms